These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 17761594)

  • 1. Mechanisms of anabolic therapies for osteoporosis.
    Canalis E; Giustina A; Bilezikian JP
    N Engl J Med; 2007 Aug; 357(9):905-16. PubMed ID: 17761594
    [No Abstract]   [Full Text] [Related]  

  • 2. Update in new anabolic therapies for osteoporosis.
    Canalis E
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1496-504. PubMed ID: 20375217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V; Clarke BL
    Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphometric changes following treatment for osteoporosis.
    Moreira CA; Dempster DW
    J Endocrinol Invest; 2017 Sep; 40(9):895-897. PubMed ID: 28550463
    [No Abstract]   [Full Text] [Related]  

  • 5. [Potential use of parathyroid hormone (PTH) in the treatments for oral diseases].
    Tanaka S; Hata K; Yoneda T
    Clin Calcium; 2012 Jan; 22(1):75-82. PubMed ID: 22201102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New anabolic agents in the treatment of osteoporosis.
    Hough S
    S Afr Med J; 2003 Oct; 93(10):754-6. PubMed ID: 14652963
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of PTH in the treatment of osteoporosis.
    Borba VZ; Mañas NC
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):213-9. PubMed ID: 20485911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN
    N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract]   [Full Text] [Related]  

  • 9. Anabolic agents and bone quality.
    Sibai T; Morgan EF; Einhorn TA
    Clin Orthop Relat Res; 2011 Aug; 469(8):2215-24. PubMed ID: 21132409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic therapies for osteoporosis.
    Uihlein AV; Leder BZ
    Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone as an anabolic therapy for women and men.
    Bilezikian JP; Rubin MR; Finkelstein JS
    J Endocrinol Invest; 2005; 28(8 Suppl):41-9. PubMed ID: 16329201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging anabolic treatments in osteoporosis.
    Mosekilde L; Tørring O; Rejnmark L
    Curr Drug Saf; 2011 Apr; 6(2):62-74. PubMed ID: 21524248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New understanding and treatments for osteoporosis.
    Mazziotti G; Bilezikian J; Canalis E; Cocchi D; Giustina A
    Endocrine; 2012 Feb; 41(1):58-69. PubMed ID: 22180055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic Therapy for Osteoporosis.
    Ensrud KE; Schousboe JT
    JAMA; 2021 Jul; 326(4):350-351. PubMed ID: 34313699
    [No Abstract]   [Full Text] [Related]  

  • 15. Anabolic bone therapies in 2014: New bone-forming treatments for osteoporosis.
    Papapoulos SE
    Nat Rev Endocrinol; 2015 Feb; 11(2):69-70. PubMed ID: 25488486
    [No Abstract]   [Full Text] [Related]  

  • 16. Mathematical Model of Bone Remodeling Captures the Antiresorptive and Anabolic Actions of Various Therapies.
    Ross DS; Mehta K; Cabal A
    Bull Math Biol; 2017 Jan; 79(1):117-142. PubMed ID: 27905067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abaloparatide and the Spine: A Narrative Review.
    Thompson JC; Wanderman N; Anderson PA; Freedman BA
    Clin Interv Aging; 2020; 15():1023-1033. PubMed ID: 32636617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential new drug targets for osteoporosis.
    Deal C
    Nat Clin Pract Rheumatol; 2009 Jan; 5(1):20-7. PubMed ID: 19098925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone as an anabolic skeletal therapy.
    Rubin MR; Bilezikian JP
    Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and pharmacological aspects of existing and experimental bone anabolic therapies.
    Chattopadhyay N
    Curr Mol Pharmacol; 2012 Jun; 5(2):125-6. PubMed ID: 21787294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.